Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial details imported from ClinicalTrials.gov
For full trial details, please see the original record at
https://clinicaltrials.gov/ct2/show/NCT01122472
Registration number
NCT01122472
Ethics application status
Date submitted
8/04/2010
Date registered
13/05/2010
Date last updated
26/07/2021
Titles & IDs
Public title
Study of Lenalidomide Maintenance Versus Placebo in Responding Elderly Patients With DLBCL and Treated With R-CHOP
Query!
Scientific title
Double Blind Randomized Phase III Study of Lenalidomide Maintenance Versus Placebo in Responding Elderly Patients With DLBCL and Treated With R-CHOP in First Line
Query!
Secondary ID [1]
0
0
REMARC
Query!
Universal Trial Number (UTN)
Query!
Trial acronym
REMARC
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
Lymphoma
0
0
Query!
Diffuse Large B-cell Lymphoma
0
0
Query!
Condition category
Condition code
Cancer
0
0
0
0
Query!
Lymphoma (non Hodgkin's lymphoma) - High grade lymphoma
Query!
Cancer
0
0
0
0
Query!
Lymphoma (non Hodgkin's lymphoma) - Low grade lymphoma
Query!
Intervention/exposure
Study type
Interventional
Query!
Description of intervention(s) / exposure
Treatment: Drugs - Lenalidomide
Treatment: Drugs - Placebo
Experimental: Lenalidomide - Lenalidomide daily for 3 weeks every 4 weeks for 24 months
Placebo Comparator: Placebo - Placebo daily for 3 weeks every 4 weeks for 24 months
Treatment: Drugs: Lenalidomide
Daily for 3 weeks every 4 weeks for 24 months
Treatment: Drugs: Placebo
Daily for 3 weeks every 4 weeks for 24 months
Query!
Intervention code [1]
0
0
Treatment: Drugs
Query!
Comparator / control treatment
Query!
Control group
Query!
Outcomes
Primary outcome [1]
0
0
Progression-Free-Survival (PFS)
Query!
Assessment method [1]
0
0
PFS will be measured from the date of randomization to the date of first documented disease progression or death. Progression data will be assigned to the earliest time when any progression is observed without prior missing assessments during the study up to the end of the follow up phase.
Query!
Timepoint [1]
0
0
Final PFS analysis will be realized when the number of events (160) has been reached or at the latest when the last patient into the study will finish follow up. The approximate schedule will be 75 months after the first patient randomized.
Query!
Secondary outcome [1]
0
0
Overall survival (OS)
Query!
Assessment method [1]
0
0
From the date of randomization to the date of death from any cause Interim analysis of OS will be performed at the time of the PFS final analysis; it is projected to have 97 deaths at this time. Final analysis of OS at the end of the study, defined by the last visit of follow-up for the last patient randomized, 5 years after its randomization
Query!
Timepoint [1]
0
0
5 years
Query!
Secondary outcome [2]
0
0
Event-Free Survival (EFS)
Query!
Assessment method [2]
0
0
From the date of randomization to the date of first documented disease progression, relapse, initiation of new anti-lymphoma therapy or death from any cause Interim analysis of EFS will be performed at the time of the PFS final analysis. Final analysis of OS at the end of the study, defined by the last visit of follow-up for the last patient randomized, 5 years after its randomization
Query!
Timepoint [2]
0
0
5 years
Query!
Secondary outcome [3]
0
0
Response rate at the end of maintenance treatment
Query!
Assessment method [3]
0
0
Query!
Timepoint [3]
0
0
24 months
Query!
Secondary outcome [4]
0
0
Percentage of patients who convert from PR (partial response) to CR (complete response)
Query!
Assessment method [4]
0
0
Query!
Timepoint [4]
0
0
24 months
Query!
Secondary outcome [5]
0
0
Safety of lenalidomide in maintenance
Query!
Assessment method [5]
0
0
Toxicities occured during maintenance phase will be measured and reported from grade 2 for infection and neurological toxicities and from grade 3 for other toxicities according to CTCAE v3
Query!
Timepoint [5]
0
0
5 years
Query!
Secondary outcome [6]
0
0
PFS2
Query!
Assessment method [6]
0
0
From randomization to objective tumor progression on next-line treatment or death from any cause
Query!
Timepoint [6]
0
0
5 years
Query!
Eligibility
Key inclusion criteria
Ages Eligible for Study: Between 60 and 80 years old
Genders Eligible for Study: Both
Accepts Healthy Volunteers: No
For patients registered at the time of initial diagnosis
- Patient with histologically proven CD20+ diffuse large B cel LYMPHOMA (DLBCL) 5WHO
classification 2008) including clinical subtypes (primitive mediastinal,
intravascular, etc.). Patients with De Novo Transformed DLBCL from low grade lymphoma
(Follicular, other..) may also be included. Patients with DLBCL associated with some
small cell infiltration in bone marrow may also be included Or CD20+ B-cell lymphoma
with intermediate features between DLBCL and Burkitt or with intermediate features
between DLBCL and classical Hodgkin lymphoma Or CD20+ Follicular lymphoma grade 3B Or
CD20+ Aggressive B-cell lymphoma unclassifiable
- previous untreated with chemo- or radiotherapy
For patients registered after response evaluation to first line treatment with R-CHOP:
- Patient with histologically proven CD20+ diffuse large B cell LYMPHOMA (DLBCL) 5WHO
classification 2008) including clinical subtypes (primitive mediastinal,
intravascular, etc.). Patients with De Novo Transformed DLBCL from low grade lymphoma
(Follicular, other..) may also be included. Patients with DLBCL associated with some
small cell infiltration in bone marrow may also be included Or CD20+ B-cell lymphoma
with intermediate features between DLBCL and Burkitt or with intermediate features
between DLBCL and classical Hodgkin lymphoma Or CD20+ Follicular lymphoma grade 3B Or
CD20+ Aggressive B-cell lymphoma unclassifiable
- Have reached a CR or PR after first line treatment with at least 6 cycles of R-CHOP 14
regimens and up to 8 cycles of R-CHOP21
- Previously untreated with Radiotherapy
For all patients:
- aged from 60 to 80 years at time of registration
- Ann Arbor stages II-IV at time of initial diagnosis
- aaIPI> 1 at time of initial diagnosis
- ECOG performance status 0-2
- Minimum life expectancy of 3 months
- Following laboratory values at screening:
- ANC= 1000.10^6/L and Platelets=60000.10^6/L
- AST<5*ULN, ALT<5*ULN, Total Bilirubin<1,5*ULN
- Creatinine clearance>30mL/min
- Women are are using effective contraception, are not pregnant and agree not to become
pregnant during participation in the trial and after end of study. Men agree not to
father a child during participation in the trial and during the 12 months thereafter.
- Having previously signed a written informed consent form
Query!
Minimum age
60
Years
Query!
Query!
Maximum age
80
Years
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
- Any other histological type of Lymphoma, Burkitt included.
- Any history of treated or non treated small B-cell lymphoma
- Central nervous system or meningeal involvement by lymphoma
- Contraindication to any drug contained in the chemotherapy regimen Myocardial
infarction during last 3 months or unstable coronary disease or uncontrolled chronic
symptomatic congestive heart insufficiency NYHA III-IV
- Uncontrolled hypertension
- Uncontrolled diabetes mellitus as defined by the investigator
- Active systemic infection requiring treatment
- previously known HIV positive serology
- Active hepatitis B or C
- Prior history of malignancies other than lymphoma within 3 years
- Serious medical or psychiatric illness
Query!
Study design
Purpose of the study
Treatment
Query!
Allocation to intervention
Randomised controlled trial
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Query!
Masking / blinding
Blinded (masking used)
Query!
Who is / are masked / blinded?
The people receiving the treatment/s
The people administering the treatment/s
The people assessing the outcomes
The people analysing the results/data
Query!
Query!
Query!
Query!
Intervention assignment
Parallel
Query!
Other design features
Query!
Phase
Phase 3
Query!
Type of endpoint/s
Query!
Statistical methods / analysis
Query!
Recruitment
Recruitment status
Completed
Query!
Data analysis
Query!
Reason for early stopping/withdrawal
Query!
Other reasons
Query!
Date of first participant enrolment
Anticipated
Query!
Actual
1/04/2009
Query!
Date of last participant enrolment
Anticipated
Query!
Actual
Query!
Date of last data collection
Anticipated
Query!
Actual
1/09/2019
Query!
Sample size
Target
Query!
Accrual to date
Query!
Final
650
Query!
Recruitment in Australia
Recruitment state(s)
Query!
Recruitment hospital [1]
0
0
Bendigo Hospital - Bendigo
Query!
Recruitment hospital [2]
0
0
Concord Repatriation General Hospital - Concord
Query!
Recruitment hospital [3]
0
0
Flinders Medical Centre - Repatriation General Hospital - Daw Park
Query!
Recruitment hospital [4]
0
0
St Vincent's Hospital, Melbourne - Fitzroy
Query!
Recruitment hospital [5]
0
0
Frankston Hospital Monash Medical Centre - Frankston
Query!
Recruitment hospital [6]
0
0
Fremantle Hospital - Fremantle
Query!
Recruitment hospital [7]
0
0
Canberra Hospital - Garran
Query!
Recruitment hospital [8]
0
0
Austin Hospital - Heidelberg
Query!
Recruitment hospital [9]
0
0
Royal Hobart Hospital - Hobart
Query!
Recruitment hospital [10]
0
0
Mater Misericordiae Hospital - Calvary Mater NewCastle - Hunter
Query!
Recruitment hospital [11]
0
0
St George Hospital - Kogarah
Query!
Recruitment hospital [12]
0
0
Sir Charles Gardiner Hospital - Nedlands
Query!
Recruitment hospital [13]
0
0
Gold Coast Hospital - Southport
Query!
Recruitment hospital [14]
0
0
Albury Base Hospital/Murray Valley Private Hospital - Wodonga
Query!
Recruitment hospital [15]
0
0
Queen Elizabeth Hospital - Woodville
Query!
Recruitment postcode(s) [1]
0
0
3550 - Bendigo
Query!
Recruitment postcode(s) [2]
0
0
2139 - Concord
Query!
Recruitment postcode(s) [3]
0
0
5000 - Daw Park
Query!
Recruitment postcode(s) [4]
0
0
3065 - Fitzroy
Query!
Recruitment postcode(s) [5]
0
0
3199 - Frankston
Query!
Recruitment postcode(s) [6]
0
0
6160 - Fremantle
Query!
Recruitment postcode(s) [7]
0
0
2606 - Garran
Query!
Recruitment postcode(s) [8]
0
0
69126 - Heidelberg
Query!
Recruitment postcode(s) [9]
0
0
7000 - Hobart
Query!
Recruitment postcode(s) [10]
0
0
2310 - Hunter
Query!
Recruitment postcode(s) [11]
0
0
2217 - Kogarah
Query!
Recruitment postcode(s) [12]
0
0
6009 - Nedlands
Query!
Recruitment postcode(s) [13]
0
0
4215 - Southport
Query!
Recruitment postcode(s) [14]
0
0
3690 - Wodonga
Query!
Recruitment postcode(s) [15]
0
0
5011 - Woodville
Query!
Recruitment outside Australia
Country [1]
0
0
Austria
Query!
State/province [1]
0
0
Feldkirch
Query!
Country [2]
0
0
Austria
Query!
State/province [2]
0
0
Innsbruck
Query!
Country [3]
0
0
Austria
Query!
State/province [3]
0
0
Leoben
Query!
Country [4]
0
0
Austria
Query!
State/province [4]
0
0
Linz
Query!
Country [5]
0
0
Austria
Query!
State/province [5]
0
0
Salzburg
Query!
Country [6]
0
0
Austria
Query!
State/province [6]
0
0
Steyr
Query!
Country [7]
0
0
Austria
Query!
State/province [7]
0
0
Vienna
Query!
Country [8]
0
0
Austria
Query!
State/province [8]
0
0
Wels
Query!
Country [9]
0
0
Belgium
Query!
State/province [9]
0
0
Antwerpen
Query!
Country [10]
0
0
Belgium
Query!
State/province [10]
0
0
Arlon
Query!
Country [11]
0
0
Belgium
Query!
State/province [11]
0
0
Bruges
Query!
Country [12]
0
0
Belgium
Query!
State/province [12]
0
0
Bruxelles
Query!
Country [13]
0
0
Belgium
Query!
State/province [13]
0
0
Charleroi
Query!
Country [14]
0
0
Belgium
Query!
State/province [14]
0
0
Chimay
Query!
Country [15]
0
0
Belgium
Query!
State/province [15]
0
0
Gent
Query!
Country [16]
0
0
Belgium
Query!
State/province [16]
0
0
Gosselies
Query!
Country [17]
0
0
Belgium
Query!
State/province [17]
0
0
Haine saint paul
Query!
Country [18]
0
0
Belgium
Query!
State/province [18]
0
0
HUY
Query!
Country [19]
0
0
Belgium
Query!
State/province [19]
0
0
Jette
Query!
Country [20]
0
0
Belgium
Query!
State/province [20]
0
0
Kortrijk
Query!
Country [21]
0
0
Belgium
Query!
State/province [21]
0
0
Liege
Query!
Country [22]
0
0
Belgium
Query!
State/province [22]
0
0
Mons
Query!
Country [23]
0
0
Belgium
Query!
State/province [23]
0
0
Namur
Query!
Country [24]
0
0
Belgium
Query!
State/province [24]
0
0
Ottignies
Query!
Country [25]
0
0
Belgium
Query!
State/province [25]
0
0
Roeselare
Query!
Country [26]
0
0
Belgium
Query!
State/province [26]
0
0
Verviers
Query!
Country [27]
0
0
Belgium
Query!
State/province [27]
0
0
Wilrijk
Query!
Country [28]
0
0
Belgium
Query!
State/province [28]
0
0
Yvoir
Query!
Country [29]
0
0
France
Query!
State/province [29]
0
0
Annecy Cedex
Query!
Country [30]
0
0
France
Query!
State/province [30]
0
0
Antibes
Query!
Country [31]
0
0
France
Query!
State/province [31]
0
0
Arras Cedex
Query!
Country [32]
0
0
France
Query!
State/province [32]
0
0
Avignon
Query!
Country [33]
0
0
France
Query!
State/province [33]
0
0
Bayonne
Query!
Country [34]
0
0
France
Query!
State/province [34]
0
0
Blois
Query!
Country [35]
0
0
France
Query!
State/province [35]
0
0
Bobigny
Query!
Country [36]
0
0
France
Query!
State/province [36]
0
0
BONDY Cedex
Query!
Country [37]
0
0
France
Query!
State/province [37]
0
0
Bordeaux
Query!
Country [38]
0
0
France
Query!
State/province [38]
0
0
Boulogne sur Mer
Query!
Country [39]
0
0
France
Query!
State/province [39]
0
0
Bourg-en-Bresse
Query!
Country [40]
0
0
France
Query!
State/province [40]
0
0
Brive-La-Gaillarde
Query!
Country [41]
0
0
France
Query!
State/province [41]
0
0
CAEN Cedex 05
Query!
Country [42]
0
0
France
Query!
State/province [42]
0
0
Caen Cedex
Query!
Country [43]
0
0
France
Query!
State/province [43]
0
0
Cannes
Query!
Country [44]
0
0
France
Query!
State/province [44]
0
0
Chalon sur Saone
Query!
Country [45]
0
0
France
Query!
State/province [45]
0
0
Chambery
Query!
Country [46]
0
0
France
Query!
State/province [46]
0
0
Chartres Cedex
Query!
Country [47]
0
0
France
Query!
State/province [47]
0
0
Clamart
Query!
Country [48]
0
0
France
Query!
State/province [48]
0
0
Colmar Cedex
Query!
Country [49]
0
0
France
Query!
State/province [49]
0
0
Compiegne Cedex
Query!
Country [50]
0
0
France
Query!
State/province [50]
0
0
Corbeil-Essonnes
Query!
Country [51]
0
0
France
Query!
State/province [51]
0
0
Créteil
Query!
Country [52]
0
0
France
Query!
State/province [52]
0
0
Dijon
Query!
Country [53]
0
0
France
Query!
State/province [53]
0
0
Dunkerque
Query!
Country [54]
0
0
France
Query!
State/province [54]
0
0
Evreux
Query!
Country [55]
0
0
France
Query!
State/province [55]
0
0
Frejus
Query!
Country [56]
0
0
France
Query!
State/province [56]
0
0
Grenoble
Query!
Country [57]
0
0
France
Query!
State/province [57]
0
0
Gueret
Query!
Country [58]
0
0
France
Query!
State/province [58]
0
0
La Rochelle Cedex 01
Query!
Country [59]
0
0
France
Query!
State/province [59]
0
0
Le Chesnay
Query!
Country [60]
0
0
France
Query!
State/province [60]
0
0
Le Kremlin-Bicêtre
Query!
Country [61]
0
0
France
Query!
State/province [61]
0
0
LE Mans
Query!
Country [62]
0
0
France
Query!
State/province [62]
0
0
Lens
Query!
Country [63]
0
0
France
Query!
State/province [63]
0
0
Lille Cedex
Query!
Country [64]
0
0
France
Query!
State/province [64]
0
0
Lille
Query!
Country [65]
0
0
France
Query!
State/province [65]
0
0
LIMOGES Cedex
Query!
Country [66]
0
0
France
Query!
State/province [66]
0
0
LYON Cedex 08
Query!
Country [67]
0
0
France
Query!
State/province [67]
0
0
Lyon
Query!
Country [68]
0
0
France
Query!
State/province [68]
0
0
Macon Cedex
Query!
Country [69]
0
0
France
Query!
State/province [69]
0
0
Marseille Cedex
Query!
Country [70]
0
0
France
Query!
State/province [70]
0
0
Marseille
Query!
Country [71]
0
0
France
Query!
State/province [71]
0
0
Meaux
Query!
Country [72]
0
0
France
Query!
State/province [72]
0
0
MELUN Cedex
Query!
Country [73]
0
0
France
Query!
State/province [73]
0
0
Metz Cedex
Query!
Country [74]
0
0
France
Query!
State/province [74]
0
0
Montpellier Cedex
Query!
Country [75]
0
0
France
Query!
State/province [75]
0
0
Mougins
Query!
Country [76]
0
0
France
Query!
State/province [76]
0
0
MULHOUSE Cedex
Query!
Country [77]
0
0
France
Query!
State/province [77]
0
0
Neuilly sur seine
Query!
Country [78]
0
0
France
Query!
State/province [78]
0
0
Nice
Query!
Country [79]
0
0
France
Query!
State/province [79]
0
0
Paris Cedex 04
Query!
Country [80]
0
0
France
Query!
State/province [80]
0
0
Paris Cedex 05
Query!
Country [81]
0
0
France
Query!
State/province [81]
0
0
Paris Cedex 13
Query!
Country [82]
0
0
France
Query!
State/province [82]
0
0
Paris
Query!
Country [83]
0
0
France
Query!
State/province [83]
0
0
Perpignan
Query!
Country [84]
0
0
France
Query!
State/province [84]
0
0
Pierre Bénite Cedex
Query!
Country [85]
0
0
France
Query!
State/province [85]
0
0
Pontoise
Query!
Country [86]
0
0
France
Query!
State/province [86]
0
0
REIMS Cedex
Query!
Country [87]
0
0
France
Query!
State/province [87]
0
0
Rouen
Query!
Country [88]
0
0
France
Query!
State/province [88]
0
0
Saint Cloud Cedex
Query!
Country [89]
0
0
France
Query!
State/province [89]
0
0
St Germain en Laye
Query!
Country [90]
0
0
France
Query!
State/province [90]
0
0
Toulon
Query!
Country [91]
0
0
France
Query!
State/province [91]
0
0
Toulouse Cedex 9
Query!
Country [92]
0
0
France
Query!
State/province [92]
0
0
Troyes Cedex
Query!
Country [93]
0
0
France
Query!
State/province [93]
0
0
Valence Cedex 9
Query!
Country [94]
0
0
France
Query!
State/province [94]
0
0
Valenciennes
Query!
Country [95]
0
0
France
Query!
State/province [95]
0
0
Vandœuvre-lès-Nancy
Query!
Country [96]
0
0
France
Query!
State/province [96]
0
0
VILLEJUIF Cedex
Query!
Country [97]
0
0
Israel
Query!
State/province [97]
0
0
Afula
Query!
Country [98]
0
0
Israel
Query!
State/province [98]
0
0
Ashkelon
Query!
Country [99]
0
0
Israel
Query!
State/province [99]
0
0
Beer sheva
Query!
Country [100]
0
0
Israel
Query!
State/province [100]
0
0
Haifa
Query!
Country [101]
0
0
Israel
Query!
State/province [101]
0
0
Kfar saba
Query!
Country [102]
0
0
Israel
Query!
State/province [102]
0
0
Petah Tikwah
Query!
Country [103]
0
0
Israel
Query!
State/province [103]
0
0
Rehovot
Query!
Country [104]
0
0
Poland
Query!
State/province [104]
0
0
Chorzow
Query!
Country [105]
0
0
Poland
Query!
State/province [105]
0
0
Krakow
Query!
Country [106]
0
0
Poland
Query!
State/province [106]
0
0
Lodz
Query!
Country [107]
0
0
Poland
Query!
State/province [107]
0
0
Warsaw
Query!
Country [108]
0
0
Poland
Query!
State/province [108]
0
0
Warszawa
Query!
Country [109]
0
0
Portugal
Query!
State/province [109]
0
0
Coimbra
Query!
Country [110]
0
0
Portugal
Query!
State/province [110]
0
0
Lisboa
Query!
Country [111]
0
0
Portugal
Query!
State/province [111]
0
0
Porto
Query!
Country [112]
0
0
Spain
Query!
State/province [112]
0
0
A coruna
Query!
Country [113]
0
0
Spain
Query!
State/province [113]
0
0
Alcorcon
Query!
Country [114]
0
0
Spain
Query!
State/province [114]
0
0
Barcelona
Query!
Country [115]
0
0
Spain
Query!
State/province [115]
0
0
El palmar
Query!
Country [116]
0
0
Spain
Query!
State/province [116]
0
0
Jerez de la frontera
Query!
Country [117]
0
0
Spain
Query!
State/province [117]
0
0
Leon
Query!
Country [118]
0
0
Spain
Query!
State/province [118]
0
0
Madrid
Query!
Country [119]
0
0
Spain
Query!
State/province [119]
0
0
Murcia
Query!
Country [120]
0
0
Spain
Query!
State/province [120]
0
0
Oviedo
Query!
Country [121]
0
0
Spain
Query!
State/province [121]
0
0
Salamanca
Query!
Country [122]
0
0
Spain
Query!
State/province [122]
0
0
Santander
Query!
Country [123]
0
0
Spain
Query!
State/province [123]
0
0
Tarragona
Query!
Country [124]
0
0
Spain
Query!
State/province [124]
0
0
Terrassa
Query!
Country [125]
0
0
Switzerland
Query!
State/province [125]
0
0
Lausanne
Query!
Funding & Sponsors
Primary sponsor type
Other
Query!
Name
The Lymphoma Academic Research Organisation
Query!
Address
Query!
Country
Query!
Ethics approval
Ethics application status
Query!
Summary
Brief summary
This study is designed as a phase III, randomized, double-blind, placebo-controlled trial to
explore the effect of maintenance therapy with lenalidomide versus placebo on
progression-free survival (PFS) in patients treated with R-CHOP responding to induction
therapy
For the primary efficacy variable, PFS, an improvement in median PFS from 38.6 months for
Treatment Arm B to 54 months for Treatment Arm A (corresponding to a 2-year PFS of 65% vs
73.6%), is considered clinically relevant.
Query!
Trial website
https://clinicaltrials.gov/ct2/show/NCT01122472
Query!
Trial related presentations / publications
Query!
Public notes
Query!
Contacts
Principal investigator
Name
0
0
Query!
Address
0
0
Query!
Country
0
0
Query!
Phone
0
0
Query!
Fax
0
0
Query!
Email
0
0
Query!
Contact person for public queries
Name
0
0
Query!
Address
0
0
Query!
Country
0
0
Query!
Phone
0
0
Query!
Fax
0
0
Query!
Email
0
0
Query!
Contact person for scientific queries
Summary Results
For IPD and results data, please see
https://clinicaltrials.gov/ct2/show/NCT01122472
Download to PDF